MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dettbarn, C.
Right arrow Articles by Palade, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dettbarn, C.
Right arrow Articles by Palade, P.

Vol. 52, Issue 6, 1124-1130, 1997

Ca2+ Feedback on "Quantal" Ca2+ Release Involving Ryanodine Receptors

Christine Dettbarn and Philip Palade

Departments of Physiology and Biophysics (C.D., P.P.) and Pharmacology and Toxicology (P.P.), University of Texas Medical Branch, Galveston, Texas 77555-0641

    Summary
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

The influence of luminal and cytoplasmic Ca2+ on the ability of ryanodine-sensitive stores to undergo multiple partial ("quantal") releases has been assessed. Increased luminal Ca2+ levels do indeed modulate sarcoplasmic reticulum Ca2+ release by lowering the threshold agonist concentration required to elicit release, but the decrease in luminal Ca2+ that accompanies a partial release is not sufficient by itself to terminate release. Similarly, an increase in cytoplasmic Ca2+ lowers the threshold agonist concentration required to elicit release; thus, the bulk cytoplasmic Ca2+ levels attained during a release would only stimulate further release, not terminate it before it reached completion. Very high cytoplasmic Ca2+ levels (1-3 mM) also triggered release but were unable to terminate release before reaching completion. Thus, even the high local cytoplasmic Ca2+ concentration that might accompany release would also not terminate release. It is concluded that Ca2+ feedback can modulate release through ryanodine receptors but that it does not account for the properties of quantal release. The low affinity inhibitor tetracaine induces a decrease in the extent of release that cannot be explained solely by heterogeneous caffeine sensitivity of the stores. The results are interpreted in terms of a scheme that includes (i) heterogeneous sensitivity of stores, conferred in part by differences in luminal Ca2+ content and (ii) adaptive behavior on the part of individual ryanodine receptors.

    Introduction
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

The ability of ryanodine receptors to mediate multiple partial releases of Ca2+ from internal stores in response to step increases in agonist concentrations has been documented by several groups (1-3). This phenomenon bears similarity to the "quantal" release of Ca2+ from internal stores sensitive to InsP3 (4). The mechanism or mechanisms responsible for these partial releases of Ca2+ remain highly controversial, with two main theories propounded. It has been proposed that receptors of heterogeneous agonist sensitivity are grouped together in isolated stores such that some stores release all their Ca2+ at low agonist concentration, and other stores follow suit only at higher agonist concentrations. In contrast to such static receptor sensitivity, it has been proposed that some other feedback mechanism regulates the agonist sensitivity of even individual release channel receptors. In its original form, this proposal involved luminal Ca2+ being the feedback system (5). Experimental demonstrations of such dynamic receptor sensitivity included the observations of a low level of steady state flux of Ca2+ from InsP3-sensitive stores (6) or the dynamic adjustment of Ca2+ sensitivity of individual ryanodine receptors in planar lipid bilayers (7). The latter result was obtained under conditions in which luminal Ca2+ concentration was low and would not have varied.

In view of the postulated involvement of luminal Ca2+ in such dynamic sensitivity and the known sensitivity of both InsP3 and ryanodine receptors to cytoplasmic Ca2+ concentration (8), we investigated further the role of Ca2+ in the quantal release of Ca2+ from internal stores involving ryanodine receptors. Our earlier study (3) showed that multiple releases take place regardless of whether released Ca2+ is resequestered, suggesting that Ca2+ redistributions do not control the partial release behavior. The results of the experiments reported here show that Ca2+ concentration changes on either side of the ryanodine receptor can modulate incremental Ca2+ release behavior, in particular by altering agonist sensitivity, but that these effects by themselves are unable to account for the stopping and restarting of release. Results with inhibitors provide additional strong evidence against multiple partial releases being due purely to true quantal behavior and in favor of a more dynamic contribution to incremental release behavior, one that does not rely primarily on luminal Ca2+ levels.

    Materials and Methods
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Heavy microsomes and purified terminal cisternae were prepared from rabbit skeletal muscle as described in Dettbarn et al. (3). Protein concentrations were determined using Coomassie Protein Assay Reagent (Pierce, Rockford, IL) using bovine serum albumin as a standard.

Spectrophotometric measurements of SR Ca2+ uptake and release were performed in a diode array spectrophotometer (HP 8451A; Hewlett Packard, Palo Alto, CA). The standard assay medium included 100 mM KCl, 20 mM K-MOPS, 2.5 mM potassium phosphate, 1 mM Mg-ATP, 5 mM Na2 phosphocreatine, 20 µg/ml creatine phosphokinase, and 0.2 mM antipyrylazo III, pH 6.8. Some experiments (see Figs. 1, 2, 3, 4) used no phosphate, with pH 6.95 medium at 37°. Extravesicular Ca2+ concentration changes were followed by measuring antipyrylazo III absorbance at A710-A790.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Caffeine sensitivity of SR stores is affected by the luminal Ca2+ content. A, Multiple Ca2+ releases in response to step increases in caffeine concentration. Rabbit microsomes (600 µg) were preloaded with 6.25 nmol of Ca2+ in 1.25-nmol increments as described in the text. Subsequently, the vesicles were challenged with increasing concentrations of caffeine as indicated. Caffeine was never removed from the cuvette. B and C, Multiple Ca2+ releases in response to caffeine when the vesicles were loaded with more Ca2+ (12.5 nmol in B, 25 nmol in C). bullet , 1.25-nmol Ca2+ additions. Arrows, 0.6 mM caffeine additions.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   The decrease in luminal Ca2+ caused by a submaximal caffeine-induced Ca2+ release cannot account for release termination. A, Heavy microsomes (380 µg) were preloaded with eight 12.5-nmol increments of Ca2+ (100 nmol total) and then challenged with 5 mM caffeine, releasing ~35 nmol Ca2+. B-D, Heavy microsomes (380 µg) were preloaded with only 62.5 nmol (B), 37.5 nmol (C), or 12.5 nmol (D) of Ca2+ and then challenged with 5 mM caffeine. Release still took place. bullet , 12.5-nmol Ca2+ additions. Arrows, 5 mM caffeine additions. Traces are representative of experiments performed in triplicate under each condition.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Homogeneously loaded SR vesicles still display multiple partial releases of Ca2+. Terminal cisternae at ~15 mg/ml were equilibrated overnight with 5 mM Ca2+/45Ca-containing solution as detailed in the text. After 100-fold dilution into EGTA-containing solution (black-square), in some cases the vesicles were challenged first with 8 mM caffeine (bullet ); in some of these experiments, the caffeine concentration was raised to 22 mM (black-triangle) 40 sec later. All experiments were performed at least in triplicate. Error bars, mean ± standard deviation. All data points at the same time point are statistically different from one another as assessed with a Student's paired t test (p < 0.05). Curves were drawn by eye.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Elevation of resting cytoplasmic Ca2+ levels increases agonist sensitivity. A, Heavy microsomes (380 µg) preloaded with 50 nmol of Ca2+ were then treated with 12.5 nmol of Ca2+ just before challenge with 1 mM caffeine. B, Microsomes were treated in the same way except that the caffeine was added before the last Ca2+ addition. bullet , 12.5 nmol Ca2+ additions. Arrows, 1 mM caffeine additions. Traces are representative of experiments performed at least in triplicate, including (B) experiments (not shown) in which 62.5 nmol of Ca2+ was preloaded before caffeine addition to compensate for any additional Ca2+ taken up (in A) before caffeine addition. Regardless of whether 50 or 62.5 nmol of Ca2+ had been preloaded, caffeine still failed to elicit release unless the extravesicular Ca2+ was elevated.

Certain 45Ca efflux determinations were carried out in the same medium at the same temperature but with 45Ca during the initial phase of preloading of endogenous Ca2+ associated with the sample. The additions of 1-3 mM Ca2+ were then made, followed by the addition of 5 mM EGTA, appropriately alkalinized to maintain pH of the final mixture. Efflux was monitored by measuring the Ca2+ remaining in the vesicles by first quenching the reaction through the addition of 100-µl aliquots to 0.9 ml of ice-cold 100 mM KCl, 20 mM MOPS, 1 mM EGTA, 10 mM MgCl2, and 20 mg/liter ruthenium red, pH 6.8. At the conclusion of each run, the quenched 1-ml mixtures were filtered by conventional manifold filtration with Millipore HAWP filters (0.45-µm effective pore size) and washing with three 3-ml washes of ice-cold quench medium.

Other 45Ca efflux determinations involved passive loading of purified terminal cisternae with 45Ca. This was achieved by first sedimenting terminal cisternae (15 mg/ml) out of their storage medium containing 10% sucrose with a 5-min full-speed spin in an airfuge (Beckman Instruments, Palo Alto, CA); resuspension in sucrose-free 100 mM KCl and 20 mM MOPS, pH 6.8, with airfuging again to wash; and resuspension in its original volume of 100 mM KCl and 20 mM MOPS, pH 6.8. To this suspension, 5 mM Ca2+ spiked with 45Ca was added, and the mixture was equilibrated overnight on ice. For efflux determinations, 10 µl of the mixture was diluted into 1 ml of 100 mM KCl, 20 mM MOPS, and 20 mM EGTA, pH 6.9 at room temperature. Three 100-µl aliquots were withdrawn at 10-sec intervals, and each was added to 0.9 ml of quench medium as described above, followed in some cases by the addition of 2-8 mM caffeine from a concentrated stock at t = 40 sec. Three additional 100-µl aliquots were then withdrawn and quenched at 10-sec intervals, followed in some cases by elevation of the caffeine concentration to 22 mM and withdrawal of three additional aliquots for quenching and subsequent filtration as described above. All isotope data were normalized with respect to the initial (t = 10 sec) time point in each series.

    Results
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Partial releases of SR Ca2+ in response to step changes of caffeine concentration are shown in Fig. 1. Because we prefer to reserve the term quantal to refer to one specific and as-yet-unproved explanation for the phenomenon, we will refer to such releases interchangeably as partial, incremental, or quantal throughout this text. In Fig. 1, multiple partial releases were obtained under conditions in which released Ca2+ was given time to be resequestered. Note that the first three additions of caffeine failed to generate any detectable release of Ca2+, and a large release with a plateau was obtained only on the fifth caffeine addition. If the amount of Ca2+ preloaded into the vesicles is increased (Fig. 1, B and C), not only are the releases of Ca2+ larger in amplitude, but the caffeine concentration required to initially activate release is reduced. Thus, the threshold concentration of agonist (caffeine) required to elicit release is lowered by increased luminal Ca2+ content. Three additional sets of experiments were carried out with 6.25, 12.5, and 18.75 nmol of Ca2+ preloading. In all experiments with 6.25 nmol of Ca2+ preloading, a large release with a plateau was obtained only on the fifth caffeine addition, whereas large releases were always obtained with the third caffeine addition if 12.5 nmol of Ca2+ had been preloaded and on the second caffeine addition when 18.75 nmol of Ca2+ had been preloaded. These differences are highly significant as assessed using a Student's paired t test.

The results of the experiments in Fig. 1 were qualitatively consistent with the original Irvine hypothesis of luminal Ca2+ controlling quantal release, but they certainly did not prove the hypothesis. To more quantitatively assess the possible contribution that this change in sensitivity might make to subsequent incremental release, we determined how much of the Ca2+ taken up had been released by caffeine. If the Irvine hypothesis were to explain quantal release, then preloading the vesicles so that their luminal content would be the same as that experienced at the time of termination of release should result in a failure of the same caffeine concentration to elicit release.

This test was applied in Fig. 2. First heavy microsomes were loaded with 100 nmol of Ca2+ and challenged with 5 mM caffeine (Fig. 2A). This concentration of caffeine was chosen to give submaximal release (the release seen at 3 mM was just detectable). The response was a release of ~35 nmol of Ca2+. We then preloaded the vesicles with progressively less Ca2+ (62.5, 37.5, or 12.5 nmol of Ca2+) before challenging them with the same concentration of caffeine. As seen in Fig. 2, a release of Ca2+ was observed under all these conditions, contrary to the predictions of the Irvine hypothesis. Similar results were obtained with another sample that released less Ca2+ in response to 4 mM caffeine (not shown) and with purified terminal cisternae that released a greater proportion of the Ca2+ taken up (not shown). Because vesicles with even less Ca2+ in them than after a release remained responsive to the same submaximal concentration of caffeine, any decrease in caffeine sensitivity caused by a release did not seem to be sufficient by itself to account for the termination of release.

A separate test was made to determine whether heterogeneously loaded stores could account for multiple partial releases of Ca2+ in response to incremental caffeine additions. To perform this test, purified terminal cisternae were passively equilibrated in 5 mM Ca2+/45Ca-containing solutions to ensure that all vesicles were uniformly loaded with Ca2+. Then, the vesicles were challenged with two steps of increasing concentration of caffeine. Although the threshold concentration of caffeine required to activate release may differ in the absence of ATP, the experiment diagrammed in Fig. 3 demonstrates that multiple responses are obtained. Similar results were obtained using 2 or 5 mM caffeine for the first caffeine challenge (not shown). Thus, the multiple responses to caffeine cannot be accounted for by populations of vesicles that are differentially loaded with Ca2+.

However, because the effect of luminal Ca2+ was at least qualitatively consistent with the Irvine hypothesis, it remained possible that some other feedback system acting in concert with the luminal Ca2+ effect could result in release termination. The most obvious candidate to explore for such a contribution is the extravesicular (cytoplasmic) Ca2+ concentration because it increases whenever a release is taking place.

Accordingly, we preloaded vesicles to the same extent with Ca2+ and then exposed them to Ca2+. Finally, the vesicles were challenged with step increases in caffeine concentration. If Ca2+ was administered in a fashion that it was not able to be appreciably sequestered before caffeine addition, then the threshold caffeine concentration required to activate release was lowered. Vesicles unresponsive to 1 mM caffeine at ambient resting Ca2+ concentration became responsive if Ca2+ was elevated just before caffeine addition (Fig. 4). This result was not surprising in that it probably represents a corollary to the much earlier observation that caffeine enhances Ca2+ sensitivity (9). In fact, it is clear from Fig. 4A that caffeine administered before Ca2+ addition led to a larger absorbance increase from the Ca2+ addition, as if some Ca2+-induced Ca2+ release had indeed occurred. This result was not in agreement with a contributory role for elevated bulk cytoplasmic Ca2+ in terminating release. However, high local Ca2+ concentrations around the mouth of a conducting release channel might be more prone to induce inactivation of that channel because such local Ca2+ concentrations could easily exceed those of the Ca2+ concentrations administered in Fig. 4.

If the vesicles were exposed to only a 2-4-fold higher extravesicular Ca2+ concentration, another effect was encountered. Releases evoked by even high caffeine concentrations were slowed and attenuated (Fig. 5). These were Ca2+ concentrations only slightly higher than those achieved at the peak of most releases (15-20 µM total Ca2+, which we calculate to be equivalent to 5-7 µM free Ca2+ under our experimental conditions at pH 6.8). The downward-going artifacts observed on caffeine additions in the presence of elevated Ca2+ might have partially obscured some remaining release.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 5.   Further elevation of resting cytoplasmic Ca2+ levels decreases subsequent caffeine-induced Ca2+ release. Heavy microsomes (380 µg) preloaded with 50 nmol of Ca2+ were then treated with 0, 25, or 50 nmol of Ca2+ just before the addition of 10 mM caffeine. Downward shifts in traces on caffeine addition are due to caffeine reduction of antipyrylazo III sensitivity to Ca2+. bullet , 12.5-nmol Ca2+ additions. Arrows, 10 mM caffeine additions. Due to its interaction with antipyrylazo III, caffeine induces a downward deflection in traces that is larger in the presence of high Ca2+. Traces are representative of at least three determinations under each condition.

To rule out further release by caffeine under such circumstances and to determine whether this inhibitory effect was due to CICR depletion of the vesicles or to an inactivating effect of the elevated extravesicular Ca2+, equivalent experiments were performed with purified terminal cisternae using the Ca2+ ionophore A23187 to assess the Ca2+ remaining in the SR after the different treatments. As seen in Fig. 6, A and B, caffeine application reduced the A23187-releasable fraction considerably, but so did before Ca2+ addition (Fig. 6C). Much less Ca2+ was left to be released by A23187 subsequent to the caffeine (4.10 ± 0.31 nmol) or Ca2+ addition in Fig. 6C (4.52 ± 0.67 nmol versus control 33.69 ± 0.05 nmol), and thus substantial CICR had occurred in response to the Ca2+ addition, probably leading to depletion rather than inactivation.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   CICR takes place even when vesicles are challenged with high cytoplasmic Ca2+. Purified terminal cisternae (300 µg) added at the first upward deflection were allowed to take up endogenous Ca2+ associated with the sample and assay solution and then challenged with 10 mM caffeine (A), 2 µM A23187 (B), or 50 nmol of Ca2+ (C). At the end of each trace, 2 µM A23187 was added, followed by 12.5 nmol of Ca2+. bullet , 12.5 nmol Ca2+ additions. Arrow, 10 mM caffeine additions. Arrowheads, 2 µM A23187 additions. Experiments shown are representative of at least three separate determinations under each condition.

In principle, high local Ca2+ concentration, which only occurs while a release channel is still conducting, could, together with a decrease in luminal Ca2+, lead to release termination. When the release terminates, the high local Ca2+ concentration would dissipate very rapidly, and the system might then soon be susceptible to reactivation easily because the decrease in luminal Ca2+ alone had not been sufficient to prevent reactivation. To determine whether any Ca2+-induced inactivation of release had also occurred, we determined whether high Ca2+ administered exogenously would lead to inactivation before depletion. As seen in Fig. 7, Ca2+ elevations of even 3 mM failed to terminate release of 45Ca before completion, and subsequent addition of EGTA (to reduce the cytoplasmic Ca2+ to a level where no inactivation would take place) failed to reactivate release because little Ca2+ remained in the SR. Similar results were obtained with 1 mM Ca2+ (not shown).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of high Ca2+ and its subsequent reduction on efflux of 45Ca. Terminal cisternae (300 µg) were actively preloaded with endogenous Ca2+ spiked with 45Ca in the presence of ATP. Aliquots were removed for Millipore filtration as described in the text. After three base-line readings, terminal cisternae treated as above were exposed to 3 mM total Ca2+ (2 mM free Ca2+) at t = 40 sec. Subsequent addition of EGTA sufficient to lower the free Ca2+ concentration to 1.5 µM at t = 80 sec failed to reactivate release. The experiment was performed four times with results expressed as mean ± standard deviation. Curve was drawn by eye.

The results thus far suggest that neither luminal nor cytoplasmic Ca2+ changes can account for multiple partial releases. Because Irvine's luminal Ca2+ regulation hypothesis represented the original alternative to true quantal behavior, does our dismissal of the luminal Ca2+ explanation represent indirect evidence in favor of true quantal behavior? To test this premise directly, we performed an additional set of experiments.

Microsomes were loaded with Ca2+ and then challenged with caffeine or caffeine in the presence of concentrations of tetracaine that only partially inhibited release. Two different concentrations of caffeine were used: one (4 mM) that elicited a clearly submaximal rate of release, and one (10 mM) that exhibited substantially larger, more prolonged release with a faster rate of release. A peculiarity of the tetracaine inhibition of release seen in Fig. 8 was that the dose-response curve (not shown) for tetracaine was unusually steep and clearly depended on the caffeine concentration. True quantal behavior would predict that the same vesicles that released (completely) in the presence of caffeine alone would also release (completely) in the presence of the low affinity antagonist tetracaine and that the amount released should be the same in the presence of tetracaine, even if the rate of release was reduced. This behavior was not observed experimentally. Instead, the amount of Ca2+ released seemed to be decreased as much as the rate of release (Fig. 8). These results suggest that some time-dependent process (either inactivation or adaptation) must have caused the release to terminate. Furthermore, it is unlikely that release termination was dependent on the length of time that conducting release channels were exposed to high local Ca2+ during release. Had this been the case, a 50% inhibition in release rate would have dictated a doubling of time necessary for any time- and Ca2+-dependent process to take place, whereas lower release rates (4 versus 10 mM caffeine or tetracaine versus controls) were associated with more rapid cessation of release.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of tetracaine on caffeine-induced Ca2+ release. Heavy microsomes (380 µg) were preloaded with 100 nmol of Ca2+ in eight 12.5-nmol increments and challenged with 4 (left) or 10 (right) mM caffeine. Top, absence of tetracaine. Experiments were then repeated with 10, 15, and 20 µM tetracaine (left; concentrations as indicated) or 20, 40, and 60 µM tetracaine (right; concentrations as indicated). Traces in the presence of tetracaine demonstrated not only reduced rates of release of calcium but also reduced amounts of Ca2+ release. The control release with 4 mM caffeine represented 10 nmol of Ca2+; that elicited by 10 mM caffeine was 13.5 nmol of Ca2+. The tetracaine-induced decreases in release amplitudes shown are representative of at least three determinations of each set of conditions. With different samples, the concentration of tetracaine needed to achieve these effects differed slightly, but tetracaine always reduced release amplitudes, and more tetracaine was required to inhibit release at higher caffeine concentrations.

    Discussion
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

The role of luminal Ca2+. Our result that termination of release occurs under Ca2+ loading conditions where the same stimulus can still elicit release (Fig. 2) leads us to conclude that luminal Ca2+ by itself does not control quantal Ca2+ release of RyRs, as in the original Irvine InsP3 receptor hypothesis. However, as suggested in that hypothesis, a decrease in luminal Ca2+ does provide a negative feedback to modulate release by increasing the threshold concentration of agonist required to elicit release. We used the concept of altered threshold to describe our results because they do not strictly discriminate between a change in affinity (sensitivity) of the RyR from a decreased cooperativity of binding. For the sake of convenience in the Discussion, we use the term "sensitivity" in its most general sense, to include either possibility. Our results are consistent with the positive feedback of increased intraluminal Ca2+ noted with isolated SR vesicles (10). Results obtained with ryanodine receptors studied in planar lipid bilayers with high intraluminal Ca2+ have been more varied. In the absence of ATP, high intraluminal Ca2+ has been reported to decrease conductance (11) or to have no effect (12), but in the more physiological presence of ATP, high intraluminal Ca2+ has a stimulatory effect on Po (12), which would be in accord with our vesicular results, also obtained in the presence of ATP. Finally, the caffeine sensitivity of Fura-2-loaded adrenal chromaffin cells was enhanced by greater luminal Ca2+ content (1). Thus, a decrease in luminal Ca2+ is not the controlling factor that terminates release for ryanodine receptors.

Experimental evidence suggests no greater role for luminal Ca2+ in regulating InsP3-induced Ca2+ release. Thus, Hannaert-Merah et al. (13) reported no effect of luminal Ca2+ on InsP3 bound, and there have been contradictory reports regarding whether partial Ca2+ depletion reduced the InsP3 sensitivity of release (14, 15). Furthermore, Ferris et al. (16) clearly found termination of rapid InsP3-mediated flux even as luminal Ca2+ was likely to be increasing.

The role of cytoplasmic Ca2+ elevations. Previously, we noted that multiple releases were obtained from SR regardless of whether extravesicular Ca2+ was allowed to remain high and concluded that it was unlikely that extravesicular (cytoplasmic) Ca2+ plays a significant role in controlling release (3). This conclusion still holds for bulk cytoplasmic Ca2+ levels. The experiments presented here suggest that even local cytoplasmic Ca2+ concentrations in the vicinity of a conducting release channel play no greater role. Although elevated local Ca2+ in the vicinity of a reconstituted single channel can inactivate it (11, 17, 18), our results suggest that any inactivation taking place in our vesicle studies is too incomplete to terminate release before vesicle depletion (Fig. 7). Our results with tetracaine and different caffeine concentrations also argue against negative feedback by released Ca2+: if release did inactivate or adapt before completion, the inactivation would have to have been independent of Ca2+ flux through the channel because the reduction in flux by tetracaine or lower caffeine did not obviously slow inactivation. Thus, local Ca2+ concentration changes by themselves also cannot account for multiple partial releases. As a consequence, our results do not support application to the RyR of the model of Swillens et al. (19), which suggests that Ca2+ conduction through a release channel is the critical factor in terminating release.

The adaptation reported by Gyorke and Fill (7) was observed in the absence of luminal Ca2+ or Ca2+ conducted through the channel and in the presence of maintained modest elevations in cytoplasmic Ca2+. Thus, single-channel studies suggest that Ca2+ concentration changes on either side of the membrane do not account for multiple bursts of channel activity. Our conclusions from this more macroscopic study of channel behavior are in agreement. Gyorke and Fill (7) have been challenged on the basis that the Ca2+ elevations they produced might have included rapid spikes to much higher levels than they measured (20). Nevertheless, because channel deactivation is very rapid (17, 21), these rapid spikes do not seem to account for the much slower reduction of channel activity attributed to adaptation (21). Some experiments involving rapid solution changes have been reported with results displaying similar slow reduction in channel activity after Ca2+ concentration increases (17, 22). Adaptation might be slower in single-channel studies than in situ (24) because Cs+ or K+ was used as the current carrier rather than Ca2+, and the Ca2+ levels achieved at the inactivating site might have been considerably smaller. It is well known that many skeletal RyRs exhibit decreased open probability when Ca2+ is elevated in the 10 µM-1 mM concentration range (8, 11), an effect manifested in vesicular studies as a diminished rate of release (23), and Tripathy and Meissner (18) concluded that Ca2+ conducted through the channel could contribute to inactivation. Low affinity Ca2+-dependent inactivation of release might still provide a mechanism for enhancing the rate of adaptation to a maintained stimulus.

With regard to InsP3 receptors, negative feedback of released Ca2+ has either not been noted (25) or when noted (26) was unmasked at such low concentrations of chelator that it could have been a pharmacological side effect of the chelator (see Ref. 27) rather than true buffering of Ca2+ at the mouth of a conducting channel. Inactivation of the InsP3 receptor by Ca2+ and by InsP3 has also been reported (28), although as in the current study, Parys et al. (29) did not consider it responsible for the quantal release they observed.

Adaptation, true quantal behavior, or both?. True quantal release in which discrete stores with different static sensitivities individually release all of their Ca2+ or none at all would not account by itself for our results with tetracaine because in that case the individual stores that were sensitive to caffeine should have continued to release all their contents, albeit at a reduced rate. Furthermore, we provided previously evidence with isolated SR that caffeine can release some Ca2+ and that when the caffeine is diluted and its concentration subsequently restored, further release is obtained (3), another argument against true quantal release. Both arguments would apply to any static sensitivity explanation for incremental release, whether it involved different sensitivities due to differences in luminal load (current study), heterotetrameric release channels (30, 31), or different release channel densities (32).

Nevertheless, differential release from discrete InsP3-sensitive stores has been documented in several more intact preparations (33-35) in which stores might not be continuous. In addition, Cheek et al. (1, 2) provided strong evidence in favor of true quantal release from caffeine sensitive stores in adrenal chromaffin cells using ryanodine to show that low caffeine concentrations activated only some channels (1). Cheek et al. (2) further determined that depletion of stores sensitive to low caffeine (achieved by multiple challenges with low caffeine in the presence of ryanodine or in the absence of Ca2+ in the medium) still revealed a large Ca2+ store sensitive to higher caffeine concentration. These results argue in favor of a heterogeneously sensitive population of stores (true quantal release) for their cells.

True quantal release and adaptation need not be mutually exclusive (36). Indeed, our results and those of Lukyanenko et al. (39) in situ indicate that discrete caffeine-sensitive stores could also become heterogeneously sensitive if they were loaded with Ca2+ to different extents. Even though adaptive behavior has been clearly shown in cardiac myocytes (24), highly localized releases (sparks) have also been described in myocytes (37), and these would be more consistent with release from discrete independently operated stores, as in true quantal release. Although stores seem discrete in skeletal myotubes, they exhibit heterogeneity in their caffeine sensitivity in a fashion that nevertheless indicates the presence of adaptation (38).

RyRs displaying adaptation in a population of heterogeneously sensitive stores could also explain three experimental results previously mentioned,which have been interpreted in favor of one interpretation or the other exclusively. First, if two successive challenges with the same submaximal caffeine concentration were administered with insufficient time allowed in-between for store reloading (3), heterogeneously sensitive stores with adapting RyRs would respond with some vesicles releasing some of their calcium on the first challenge, and then the second challenge would result in additional release, as observed (3), because the same vesicles released more calcium. Second, if a submaximal caffeine concentration elicited partial release, the effect of a low affinity inhibitor like tetracaine on heterogeneously sensitive stores with adapting RyRs would be to have the same vesicles releasing calcium at a lower rate for the same period of time, with the final result of a release of a smaller amount of calcium, as observed here (Fig. 8). In the third case, if heterogeneously sensitive stores with adapting RyRs were exposed to multiple challenges with the same caffeine concentration under conditions that they were unable to reload (2), the first challenge would result in some stores releasing some of their calcium. With subsequent challenges the same stores would release more of their calcium until they became depleted, but other less sensitive stores would retain their calcium until a much higher caffeine concentration was applied, as observed (2).

These arguments raise the spector that several different processes may together result in the unique phenomenon of multiple partial releases of Ca2+ stores in response to incrementally increasing agonist concentrations. If heterogeneous sensitivity can be conferred by luminal Ca2+, as our results indicate, then the density of pump sites in individual stores could be an important determinant of store sensitivity. Whatever mechanism accounts for the adaptive contribution to quantal release, it will have to abide by the thermodynamic constraints identified by Stern (40). Regardless of the mechanisms that cause it, the incremental nature of this quantal release undoubtedly also contributes to the graded nature of releases involving both the RyR and the InsP3 receptor, systems that would otherwise be expected to become all-or-none due to the positive feedback of released Ca2+ on further release.

    Footnotes

Received May 19, 1997; Accepted August 26, 1997

   This work was supported by National Institutes of Health Grant AR43200.

Send reprint requests to: Dr. Philip Palade, Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston, TX 77555-0641. E-mail: philip.palade{at}utmb.edu

    Abbreviations

CICR, Ca2+-induced Ca2+ release; EGTA, ethylene glycol bis(beta -aminoethyl ether)-N,N,N',N'-tetraacetic acid; InsP3, inositol-1,4,5-trisphosphate; MOPS, 3-(N-morpholino)propanesulfonic acid; RyR, ryanodine receptor; SR, sarcoplasmic reticulum.

    References
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

1. Cheek, T. R., R. B. Moreton, M. J. Berridge, K. A. Stauderman, M. M. Murawsky, and M. D. Bootman. Quantal Ca2+ release from caffeine-sensitive stores in adrenal chromaffin cells. J. Biol. Chem.  268:27076-27083 (1993)[Abstract/Free Full Text].
2. Cheek, T. R., M. J. Berridge, R. B. Moreton, K. A. Stauderman, M. M. Murawsky, and M. D. Bootman. Quantal Ca2+ mobilization by ryanodine receptors is due to all-or-none release from functionally discrete intracellular stores. Biochem. J.  301:879-883 (1994).
3. Dettbarn, C., S. Gyorke, and P. Palade. Many agonists induce "quantal" Ca2+ release or adaptive behavior in muscle ryanodine receptors. Mol. Pharmacol.  46:502-507 (1994)[Abstract].
4. Muallem, S., S. J. Pandol, and T. G. Beeker. Hormone-evoked calcium release from intracellular stores is a quantal process. J. Biol. Chem.  264:205-212 (1989)[Abstract/Free Full Text].
5. Irvine, R. F. `Quantal' Ca2+ release and the control of Ca2+ entry by inositol phosphates: a possible mechanism. FEBS Lett.  263:5-9 (1990)[Medline].
6. Missiaen, L., H. De Smedt, G. Droogmans, and R. Casteels. Ca2+ release induced by inositol 1,4,5-trisphosphate is a steady-state phenomenon controlled by luminal Ca2+ in permeabilized cells. Nature (Lond.)  357:599-602 (1992)[Medline].
7. Gyorke, S. and M. Fill. Ryanodine receptor adaptation: control mechanism of Ca2+-induced Ca2+ release in heart. Science (Washington D. C.)  260:807-809 (1993)[Abstract/Free Full Text].
8. Bezprozvanny, I., J. Watras, and B. E. Ehrlich. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature (Lond.)  351:751-754 (1991)[Medline].
9. Endo, M. Mechanism of action of caffeine on the sarcoplasmic reticulum of skeletal muscle. Proc. Jpn. Acad.  51:479-484 (1975).
10. Nelson, T. E. and K. E. Nelson. Intra- and extraluminal sarcoplasmic reticulum regulatory sites for Ca2+-induced Ca2+ release. FEBS Lett.  263:292-294 (1990)[Medline].
11. Ma, J., M. Fill, C. M. Knudson, K. P. Campbell, and R. Coronado. Ryanodine receptor of skeletal muscle is a gap junction-type channel. Science (Washington D. C.)  242:99-102 (1988)[Abstract/Free Full Text].
12. Sitsapesan, R. and A. J. Williams. The gating of the sheep skeletal sarcoplasmic reticulum Ca2+ release channel is regulated by luminal Ca2+. J. Membr. Biol.  146:133-144 (1995)[Medline].
13. Hannaert-Merah, J.-F. Coquil, L. Combettes, M. Claret, J.-P. Mauger, and P. Champeil. Rapid kinetics of myo-inositol trisphosphate binding and dissociation in cerebellar microsomes. J. Biol. Chem.  269:29642-29649 (1994)[Abstract/Free Full Text].
14. Nunn, D. L. and C. W. Taylor. Luminal Ca2+ increases the sensitivity of Ca2+ stores to inositol 1,4,5-trisphosphate. Mol. Pharmacol.  41:115-119 (1992)[Abstract].
15. Shuttleworth, T. J. Ca2+ release from inositol trisphosphate-sensitive stores is not modulated by intraluminal [Ca2+]. J. Biol. Chem.  267:3573-3576 (1992)[Abstract/Free Full Text].
16. Ferris, C. D., A. M. Cameron, R. L. Huganir, and S. H. Snyder. Quantal calcium release by purified inositol 1,4,5-trisphosphate receptors. Nature (Lond.)  356:350-352 (1992)[Medline].
17. Schiefer, A., G. Meissner, and G. Isenberg. Ca2+ activation and Ca2+ inactivation of canine reconstituted cardiac sarcoplasmic reticulum Ca2+ release channels. J. Physiol. (Lond.)  489:337-348 (1995)[Medline].
18. Tripathy, A. and G. Meissner. Sarcoplasmic reticulum lumenal Ca2+ has access to cytosolic activation and inactivation sites of skeletal muscle Ca2+ release channel. Biophys. J.  70:2600-2615 (1996)[Abstract/Free Full Text].
19. Swillens, S., L. Combettes, and P. Champeil. Transient inositol 1,4,5-trisphosphate-induced Ca2+ release: a model based on regulatory Ca2+ binding sites along the permeation pathway. Proc. Natl. Acad. Sci. USA  91:10074-10078 (1994)[Abstract/Free Full Text].
20. Lamb, G. D., M. W. Fryer, and D. G. Stephenson. Ca2+-induced Ca2+ release in response to flash photolysis. Science (Washington D. C.)  263:986-987 (1994)[Free Full Text].
21. Velez, P., S. Gyorke, A. L. Escobar, J. Vergara, and M. Fill. Adaptation of single cardiac ryanodine receptor channels. Biophys. J.  72:691-697 (1997)[Medline].
22. Laver, D. R. and B. A. Curtis. Response of ryanodine receptor channels to Ca2+ steps produced by rapid solution exchange. Biophys. J.  71:732-741 (1996)[Abstract/Free Full Text].
23. Kim, D. H., S. T. Ohnishi, and N. Ikemoto. Kinetic studies of calcium release from sarcoplasmic reticulum in vitro. J. Biol. Chem.  258:9662-9668 (1983)[Abstract/Free Full Text].
24. Yasui, K., P. Palade, and S. Gyorke. Negative control mechanism with features of adaptation controls Ca2+ release in cardiac myocytes. Biophys. J.  67:457-460 (1994)[Abstract/Free Full Text].
25. Bootman, M. D., L. Missiaen, J. B. Parys, H. De Smedt, and R. Casteels. Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+. Biochem. J.  306:445-451 (1995).
26. Iino, M. and M. Endo. Calcium-dependent immediate feedback control of inositol 1,4,5-trisphosphate-induced Ca2+ release. Nature (Lond.)  360:76-78 (1992)[Medline].
27. Richardson, A. and C. W. Taylor. Effects of Ca2+ chelators on purified inositol 1,4,5-trisphosphate (InsP3) receptors and InsP3-stimulated Ca2+ mobilization. J. Biol. Chem.  268:11528-11533 (1993)[Abstract/Free Full Text].
28. Hajnoczky, G. and A. P. Thomas. The inositol trisphosphate calcium channel is inactivated by inositol trisphosphate. Nature (Lond.)  370:474-477 (1994)[Medline].
29. Parys, J. B., L. Missiaen, H. De Smedt, I. Sienaert, R. H. Henning, and R. Casteels. Quantal release of calcium in permeabilized A7r5 cells is not caused by intrinsic inactivation of the inositol trisphosphate receptor. Biochem. Biophys. Res. Commun.  209:451-456 (1995)[Medline].
30. Monkawa, T., A. Miyawaki, T. Sugiyama, H. Yoneshima, M. Yamamoto-Hino, T. Furuichi, T. Saruta, M. Hasegawa, and K. Mikoshiba. Heterotetrameric complex formation of inositol 1,4,5-trisphosphate receptor subunits. J. Biol. Chem.  270:14700-14704 (1994)[Abstract/Free Full Text].
31. Watras, J., I. Moraru, D. J. Costa, and L. Allen Kindman. Two inositol 1,4,5-trisphosphate binding sites in rat basophilic leukemia cells: relationship between receptor occupancy and calcium release. Biochemistry  33:14359-14367 (1994)[Medline].
32. Hirose, K. and M. Iino. Heterogeneity of channel density in inositol-1,4,5-trisphosphate-sensitive Ca2+ stores. Nature (Lond.)  372:791-794 (1994)[Medline].
33. Parker, I. and I. Ivorra. Localized all-or-none calcium liberation by inositol 1,4,5-trisphosphate. Science (Washington D. C.)  250:977-979 (1990)[Abstract/Free Full Text].
34. Short, A. D., M. G. Klein, M. F. Schneider, and D. L. Gill. Inositol 1,4,5-trisphosphate-mediated quantal Ca2+ release measured by high resolution imaging of Ca2+ within organelles. J. Biol. Chem.  268:25887-25893 (1993)[Abstract/Free Full Text].
35. Renard-Rooney, D. C., G. Hajnoczky, M. B. Seitz, T. G. Schneider, and A. P. Thomas. Imaging of inositol 1,4,5-trisphosphate-induced Ca2+ fluxes in single permeabilised hepatocytes. J. Biol. Chem.  268:23601-23610 (1993)[Abstract/Free Full Text].
36. Parys, J. B., L. Missiaen, H. De Smedt, I. Sienaert, and R. Casteels. Mechanisms responsible for quantal Ca2+ release from inositol trisphosphate-sensitive calcium stores. Pflueg. Arch. Eur. J. Physiol.  432:359-367 (1996). [Medline]
37. Cheng, H., W. J. Lederer, and M. B. Cannell. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science (Washington D. C.)  262:740-744 (1993)[Abstract/Free Full Text].
38. Gyorke, I. and S. Gyorke. Adaptive control of intracellular Ca2+ release in C2C12 mouse myotubes. Pflueg. Arch. Eur. J. Physiol.  431:838-843 (1996). [Medline]
39. Lukyanenko, V., I. Gyorke, and S. Gyorke. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflueg. Arch. Eur. J. Physiol.  432:1047-1054 (1996). [Medline]
40. Stern, M. D. `Adaptive' behavior of ligand-gated ion channels: constraints by thermodynamics. Biophys. J.  70:2100-2109 (1996)[Abstract/Free Full Text].


0026-895X/97/061124-07$3.00/0
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. Masaki, N. Yasokawa, M. Tohnishi, T. Nishimatsu, K. Tsubata, K. Inoue, K. Motoba, and T. Hirooka
Flubendiamide, a Novel Ca2+ Channel Modulator, Reveals Evidence for Functional Cooperation between Ca2+ Pumps and Ca2+ Release
Mol. Pharmacol., May 1, 2006; 69(5): 1733 - 1739.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
T. R. Shannon, F. Wang, and D. M. Bers
Regulation of Cardiac Sarcoplasmic Reticulum Ca Release by Luminal [Ca] and Altered Gating Assessed with a Mathematical Model
Biophys. J., December 1, 2005; 89(6): 4096 - 4110.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
T. R. Shannon, F. Wang, J. Puglisi, C. Weber, and D. M. Bers
A Mathematical Treatment of Integrated Ca Dynamics within the Ventricular Myocyte
Biophys. J., November 1, 2004; 87(5): 3351 - 3371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Lloyd-Evans, D. Pelled, C. Riebeling, J. Bodennec, A. de-Morgan, H. Waller, R. Schiffmann, and A. H. Futerman
Glucosylceramide and Glucosylsphingosine Modulate Calcium Mobilization from Brain Microsomes via Different Mechanisms
J. Biol. Chem., June 20, 2003; 278(26): 23594 - 23599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X.-L. Cui, W.-W. Jin, Y.-X. Ding, L. D. Alexander, U. Hopfer, and J. G. Douglas
Ca2+-dependent activation of c-jun NH2-terminal kinase in primary rabbit proximal tubule epithelial cells
Am J Physiol Cell Physiol, August 1, 2000; 279(2): C403 - C409.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Koizumi, P. Lipp, M. J. Berridge, and M. D. Bootman
Regulation of Ryanodine Receptor Opening by Lumenal Ca2+ Underlies Quantal Ca2+ Release in PC12 Cells
J. Biol. Chem., November 19, 1999; 274(47): 33327 - 33333.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. R. Shannon, G. Chu, E. G. Kranias, and D. M. Bers
Phospholamban Decreases the Energetic Efficiency of the Sarcoplasmic Reticulum Ca Pump
J. Biol. Chem., March 2, 2001; 276(10): 7195 - 7201.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dettbarn, C.
Right arrow Articles by Palade, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dettbarn, C.
Right arrow Articles by Palade, P.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics